P2Y6R is associated with adipose inflammation and muscle wasting in pancreatic cancer cachexia
Life Sciences · 2026-11 · 124757
DOI: 10.1016/j.lfs.2026.124757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-11. Verfasst von Jinyoung Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, 21983, Republic of Korea. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pancreatic cancer has one of the highest incidences of cancer-associated cachexia, a multi-organ wasting syndrome driven by complex tumor-host interactions. Although adipose tissue functions as an active endocrine organ contributing to systemic inflammation, the mechanisms linking adipose inflammation to skeletal muscle wasting remain incompletely understood. METHODS: An orthotopic pancreatic tumor mouse model was combined with pharmacological P2Y6R inhibition using MRS2578. Cachexia-associated targets were identified by transcriptomic analysis of mouse datasets, and P2Y6R function was examined in vitro cancer-associated adipocyte (CAA) and C2C12 myotube models. RESULTS: Transcriptomic analysis identified P2Y6R as a cachexia-associated gene, with expression selectively upregulated in visceral adipose tissue and CAAs under pancreatic cancer conditions. In contrast, P2Y6R expression was minimal in skeletal muscle and comparatively low in tumor tissue. In the orthotopic model, pharmacological inhibition of P2Y6R with MRS2578, initiated before overt weight loss, attenuated body weight loss. This was accompanied by reduced serum IL-6 and IL-1β levels (IL-1β at 3 mg/kg only) and decreased expression of the atrogenes mRNA expression in skeletal muscle. In vitro, conditioned medium from CAAs suppressed myotube differentiation, whereas P2ry6 knockdown in adipocytes attenuated this effect. Mechanistically, the P2Y6R-dependent secretome of cancer-associated adipocytes was associated with increased atrogene expression and altered FOXO3 phosphorylation in myotubes. CONCLUSIONS: Our findings indicate that P2Y6R is associated with adipose inflammation and muscle wasting in pancreatic cancer cachexia, and that pharmacological P2Y6R inhibition attenuates cachexia progression in a preventive setting. These results suggest a potential contribution of adipocyte P2Y6R to adipose-muscle crosstalk and highlight P2Y6R as a candidate therapeutic target for cancer-associated muscle loss.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, 21983, Republic of Korea.
- College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, 21983, Republic of Korea; Yonsei University Institute of Advanced Bio-Industry Convergence, Incheon, 21983, Republic of Korea…
Zitieren
APA
Kim, J., Chae, J., & Choi, J. (2026). P2Y6R is associated with adipose inflammation and muscle wasting in pancreatic cancer cachexia. Life Sciences, 124757. https://doi.org/10.1016/j.lfs.2026.124757
Vancouver
Kim J, Chae J, Choi J. P2Y6R is associated with adipose inflammation and muscle wasting in pancreatic cancer cachexia. Life Sciences. 2026:124757. doi:10.1016/j.lfs.2026.124757
BibTeX
@article{Kim2026,
author = {Kim, Jinyoung and Chae, Jeehoon and Choi, Junjeong},
title = {P2Y6R is associated with adipose inflammation and muscle wasting in pancreatic cancer cachexia},
journal = {Life Sciences},
year = {2026},
pages = {124757},
doi = {10.1016/j.lfs.2026.124757}
}
EUVIMED